Peter Eickelmann

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors

Rolf Grempler, Leo Thomas, Matthias Eckhardt et al. · Diabetes Obesity and Metabolism · 2011 · 603 citations

Medicine, Pharmacokinetics, Pharmacology +17

Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies

Wolfgang A. Schulz, Angelika Krummeck, Ingrid R singer et al. · Pharmacogenetics · 1997 · 150 citations

Medicine, Genetics, Oncology +11

Functional characterisation of human SGLT‐5 as a novel kidney‐specific sodium‐dependent sugar transporter

Rolf Grempler, Robert Augustin, Stefanie Froehner et al. · FEBS Letters · 2011 · 81 citations

Life Sciences, Biochemistry, Nephrology +13

Design of Selective Peptidomimetic Agonists for the Human Orphan Receptor BRS-3

Dirk Weber, C Berger, Peter Eickelmann et al. · Journal of Medicinal Chemistry · 2003 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Loss of Heterozygosity at the NAD(P)H:Quinone Oxidoreductase Locus Associated with Increased Resistance against Mitomycin C in a Human Bladder Carcinoma Cell Line

Peter Eickelmann, Wolfgang A. Schulz, Bernd J. Schmitz‐Dräger et al. · Biological Chemistry Hoppe-Seyler · 1994 · 51 citations

Medicine, Molecular Biology, Molecular Genetics +14